C
Cerus Corporation
CERS · NASDAQ · Healthcare · 601M
Closing price
$2.30
+0.88% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
6.7×
Enterprise value / EBITDAEV/EBITDA
-93.5×
Free cash flow yieldFCF yield
1.9%
Return on equityROE
-24.3%
Operating margin
-4.2%
Net debt / EBITDAbalance-sheet strength
-14.0×
Interest coverage
-1.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.